Grossman will evaluate your lab work, symptoms, and history before recommending this therapy
Targeting the brain directly: Experiments involving the direct injection of GLP-1 into the brain, or the selective activation of central GLP-1-producing neurons, have consistently shown a strong link between central GLP-1 action and reduced food intake
We've seen firsthand the frustrating and costly results of experiments gone wrong, all because a vial was left on a lab bench over a weekend
Unfortunately, private coverage remains equally problematicfew insurance companies provide coverage for second-generation medications like GLP-1 receptor agonists, often requiring diabetes as a prerequisite for prescription coverage
Notably, unexpected AEs such as incorrect dosing, off-label use, extra doses, inappropriate administration schedules, and elevated blood glucose levels were also frequently reported